In this landscape, growing evidence discloses how β-arr1 connects the ETAR signaling with other pathways fostering ETAR-intertwined signalings critically involved in the metastatic progression and drug response in many tumor types, including ovarian cancer [20–38]. Here, EDNRA is linked to ovarian carcinoma.